ZYN’s FDA Modified-Risk Label Could Be A Game Changer For Philip Morris International (PM)
Philip Morris International's ZYN nicotine pouches have received Modified Risk Tobacco Product (MRTP) orders from the FDA, allowing marketing claims that switching from cigarettes to ZYN lowers the risk of several serious smoking-related diseases. This status could significantly boost PM's smoke-free product growth narrative, although regulatory and tax risks, as well as consumer adoption rates, remain critical uncertainties for investors. The company's financial strategy, including a recent debt prepayment, aims to support its shift towards smoke-free alternatives like ZYN and IQOS.
Addison Capital Co Buys 7,793 Shares of Philip Morris International Inc. $PM
Addison Capital Co significantly increased its stake in Philip Morris International (PM) by 32.5% in the first quarter, now holding 31,779 shares valued at over $5.25 million. This move is consistent with broader institutional interest, as hedge funds own 78.63% of the company's stock. Analysts maintain a "Moderate Buy" rating for PM, with an average target price of $194.62, following strong quarterly earnings and revenue performance.
Zyn’s Popularity Has Tobacco Companies Racing to Cash In
The popularity of nicotine pouches, particularly Zyn, is driving significant investment from tobacco companies in new manufacturing plants across the U.S. This expansion aims to capitalize on projected sales growth to over $40 billion by 2033, offsetting declining cigarette sales. However, this trend is raising public health concerns due to nicotine's addictive nature and potential harm, especially to adolescents, reminiscent of past issues with flavored vaping products.
UBS Lifts Philip Morris International (PM) Price Target by $14
UBS has increased its price target for Philip Morris International (PM) from $168 to $182, while maintaining a 'Neutral' rating. The company is transitioning from traditional cigarettes to next-generation nicotine products, with smoke-free innovations now accounting for 41% of revenue and high gross margins. Philip Morris is also recognized for its strong shareholder commitment, having grown its annual dividend significantly since 2008.
UBS Lifts Philip Morris International (PM) Price Target by $14
UBS has increased its price target for Philip Morris International (PM) from $168 to $182, while maintaining a 'Neutral' rating. The company is transitioning from traditional cigarettes to next-gen nicotine products, with smoke-free alternatives now accounting for 41% of revenue and high gross margins. Philip Morris is also recognized for its consistent dividend growth since 2008.
Philip Morris International Inc. stock outperforms competitors on strong trading day
Philip Morris International Inc. (PM) shares advanced 1.64% to $187.79 on Tuesday, outperforming the broader stock market which saw the S&P 500 Index (SPX) fall 0.45% and the Dow Jones Industrial Average (DJIA) fall 0.25%. This marks the stock's third consecutive day of gains despite a grim trading session.
Hodges Capital Management Inc. Raises Stock Holdings in Philip Morris International Inc. $PM
Hodges Capital Management Inc. significantly increased its stake in Philip Morris International (NYSE:PM) by 575.9% in the first quarter, now holding 11,950 shares valued at $1.98 million. This surge in holdings follows Philip Morris International's strong Q1 earnings, which surpassed analyst expectations with an EPS of $1.96 and revenue of $10.15 billion. The company also announced a quarterly dividend of $1.47 per share, contributing to a 3.2% yield, while analysts maintain a "Moderate Buy" rating with a consensus price target of $194.62.
ETFs Investing in Burke Herbert Financial Services Corp Stocks
This article lists various ETFs that currently hold stocks of Burke & Herbert Financial Services Corp. (BHRB). The ETFs are sorted by market value and include details such as issuer, management style, expense ratio, AUM, price, and 3-year NAV total return. The information provides investors with an overview of how different ETFs incorporate BHRB into their portfolios, primarily focusing on small-cap and financial sector funds.
UBS Adjusts Price Target on Altria Group to $79 From $76
UBS has increased its price target on Altria Group (MO) shares to $79 from $76. The report, published on July 7, 2026, indicates this adjustment reflects an updated outlook for the tobacco company.
Philip Morris International Inc. stock outperforms competitors on strong trading day
Philip Morris International Inc. (PM) stock rose by 1.37% to $184.76 on Monday, outperforming the broader market. This gain occurred on a strong trading day where the S&P 500 Index (SPX) increased by 0.72% and the Dow Jones Industrial Average (DJIA) rose by 0.29%. This marks the stock's second consecutive day of gains.
Altria vs. Philip Morris International: Tobacco Still Makes a Great Stock. Which Is a Better Buy in 2026?
This article compares Altria Group (MO) and Philip Morris International (PM) as investment options in 2026, highlighting their respective market positions and growth strategies. Altria maintains domestic dominance with traditional and oral nicotine products, while Philip Morris International leads global innovation in smoke-free alternatives. The authors concluded that Altria's strong dividend and moderate valuation make it a better buy for income-focused investors despite its slower revenue growth projections.
British American Tobacco Is Cutting 5,500 Jobs. How to Play the High-Yield Dividend Stock Here.
British American Tobacco (BTI) is implementing a significant restructuring, cutting 5,500 jobs and moving 3,500 roles to third-party firms, driven by an AI-led cost reduction and profit-boosting strategy. This move, which does not affect its largest market, the U.S., comes as the company shifts its focus from traditional combustible tobacco products to reduced-risk alternatives. Analysts maintain a generally positive outlook on the stock, citing its strong dividend yield, strategic shift, and defensive characteristics, despite potential regulatory challenges and a decline in long-term smoking rates.
Whittier Trust Co. Sells 98,464 Shares of Philip Morris International Inc. $PM
Whittier Trust Co. recently reduced its stake in Philip Morris International Inc. by 25.9%, selling 98,464 shares and retaining 281,824 shares worth approximately $45.2 million. This comes as Philip Morris reported stronger-than-expected Q1 earnings of $1.96 per share and $10.15 billion in revenue, representing a 9.1% year-over-year increase. The company also declared a quarterly dividend of $1.47 per share, yielding an annualized 3.2%, while analysts maintain a "Moderate Buy" rating with a consensus price target of $194.62.
Bogart Wealth LLC Increases Stake in Philip Morris International Inc. $PM
Bogart Wealth LLC significantly increased its stake in Philip Morris International Inc. (NYSE:PM) by 46.4% in the first quarter, now holding 82,348 shares valued at approximately $13.6 million. Other major institutional investors like Vanguard Group Inc. and Capital World Investors also boosted their positions, contributing to the overall 78.63% institutional ownership of the stock. Philip Morris International reported stronger-than-expected earnings and revenue in its latest quarter, and analysts currently rate the stock as a "Moderate Buy" with an average target price of $194.62.
The Marlboro Special Blend from Altria Group Inc. - stable US volume driver
The Marlboro Special Blend from Altria Group Inc. is highlighted as a key product within the company's Marlboro franchise, aimed at US adult smokers seeking a smoother taste. This blend helps Altria retain brand loyalty and maintain premium cigarette volumes amidst a broader strategy to expand into smoke-free products. The article emphasizes its role in the company's portfolio despite declining overall cigarette volumes, contributing to stable cash flow for investors.
Ascentis Independent Advisors Increases Stock Position in Philip Morris International Inc. $PM
Ascentis Independent Advisors significantly increased its stake in Philip Morris International (NYSE:PM) by 97.1% in the first quarter of 2026, bringing its total holdings to 17,820 shares valued at approximately $2.95 million. This comes after Philip Morris International reported stronger-than-expected quarterly earnings and revenue, and declared a quarterly dividend of $1.47 per share, yielding 3.2%. The company's stock has also seen a "Moderate Buy" consensus rating from analysts, with a target price of $194.62.
GM Advisory Group LLC Sells 29,742 Shares of Philip Morris International Inc. $PM
GM Advisory Group LLC significantly reduced its stake in Philip Morris International (NYSE:PM) by 68.8% in the first quarter, selling 29,742 shares and retaining 13,470 shares valued at approximately $2.23 million. Despite this, institutional ownership remains high at 78.63%, with other large firms increasing their positions. Philip Morris International reported strong quarterly results, beating EPS and revenue expectations, and declared a $1.47 quarterly dividend, equating to a 3.2% annual yield.
QRG Capital Management Inc. Increases Position in Philip Morris International Inc. $PM
QRG Capital Management Inc. significantly increased its stake in Philip Morris International Inc. by 21.7% in the first quarter, bringing its total holdings to $39.14 million. Other institutions also adjusted their positions in the company. Philip Morris International reported strong first-quarter earnings, beating analyst estimates, and announced a quarterly dividend of $1.47 per share.
Altria Stock’s 27% YTD Rally: Does the Math Still Support More Upside in 2026?
Altria Group (MO) saw a 7.3% adjusted diluted EPS growth in Q1 2026, driven by a shift in consumer behavior back to cigarettes and nicotine pouches, with on! shipments increasing 18%. However, a new FDA "enforcement discretion" policy for vapes could reverse this trend, posing a risk to future growth. While Altria stock trades above the Street's mean target of $70, TIKR's mid-case model projects an $86 target by December 2030, suggesting a more moderate, steady compounder rather than a re-rating story, especially if vape rule changes impact on!'s volume gains.
HB Wealth Management LLC Purchases 7,649 Shares of Philip Morris International Inc. $PM
HB Wealth Management LLC increased its stake in Philip Morris International (PM) by 8.0% in the first quarter, acquiring an additional 7,649 shares to bring its total holdings to 102,958 shares valued at approximately $17.0 million. This move comes as other institutional investors have also adjusted their positions in PM. Philip Morris International reported strong quarterly results, with earnings beating estimates and revenue increasing by 9.1% year-over-year, and has declared a quarterly dividend of $1.47 per share.
Is Philip Morris International (PM) Fully Priced On Its Landmark FDA Nod For ZYN?
Philip Morris International stock is under scrutiny following FDA authorization for 20 ZYN nicotine pouch variants. While the most popular narrative suggests a 5.6% undervaluation with a fair value of $193.14, the current P/E ratio of 25.7x makes it appear expensive compared to industry averages and its own fair ratio. Investors are urged to review the data to weigh the potential upside against risks.
ZYN turns 250th anniversary art into collectible cases
Philip Morris International (NYSE:PM) announced the ZYN America250 Art Series, a cultural initiative from its nicotine pouch brand ZYN, to celebrate America's 250th anniversary. The series will feature original works by selected American and U.S.-based artists, adapted into limited-edition collectible metal ZYN cases, available first to ZYN Rewards members and later through e-commerce and retailers. This initiative is part of PMI U.S.'s broader America250 cultural and community programming, aimed at celebrating artistic expression and investing in creative talent.
ZYN becomes first nicotine pouch with FDA modified risk orders | PMI
The FDA has issued modified risk tobacco product (MRTP) orders for 20 variants of Philip Morris International’s ZYN nicotine pouches, allowing them to be marketed with reduced-risk claims compared to cigarettes. This marks ZYN as the first nicotine pouch to receive such authorization, providing adult nicotine consumers with science-based information on lower health risks. The decision highlights the FDA's rigorous scientific review process for nicotine products and reinforces PMI's position as an industry leader in reduced-risk alternatives.
Y Intercept Hong Kong Ltd Takes Position in Philip Morris International Inc. $PM
Y Intercept Hong Kong Ltd has established a new position in Philip Morris International Inc. by acquiring 133,907 shares valued at $22.1 million in the first quarter, representing 0.4% of its holdings. This move aligns with a "Moderate Buy" consensus from analysts, who have set an average price target of $194.62. Philip Morris recently surpassed earnings expectations with $1.96 EPS on $10.15 billion in revenue and declared a quarterly dividend of $1.47 per share, offering a 3.2% yield.
New York State Teachers Retirement System Sells 12,713 Shares of Philip Morris International Inc. $PM
The New York State Teachers Retirement System reduced its stake in Philip Morris International Inc. by 1.0% in the first quarter of 2026, selling 12,713 shares. Despite this, the institutional investor still owned 1,276,875 shares valued at $211.12 million. Other institutional investors also adjusted their holdings, with 78.63% of the stock currently owned by hedge funds and institutions.
Elevation Point Wealth Partners LLC Purchases 32,382 Shares of Philip Morris International Inc. $PM
Elevation Point Wealth Partners LLC significantly increased its stake in Philip Morris International Inc. (NYSE:PM) during the first quarter, purchasing 32,382 additional shares and bringing its total holdings to $7.45 million. Institutional investors collectively own 78.63% of PM shares. Despite market fluctuations, analysts generally maintain a "Moderate Buy" rating for Philip Morris International, with an average price target of $194.62, and the company recently announced a quarterly dividend of $1.47 per share.
Philip Morris International Inc. stock outperforms competitors on strong trading day
Shares of Philip Morris International Inc. (PM) advanced 2.58% to $182.27 on Thursday, outperforming the S&P 500 Index and the Dow Jones Industrial Average on a mixed trading day. This rise follows a two-day losing streak for the company's stock.
Philip Morris’ Safer Products Are Winning With Regulators. They’ll Win With Investors Too.
Philip Morris International is seeing success with its safer products, which are gaining regulatory approval and driving company growth. The stock is considered a reliable investment due to expanding margins from smokeless tobacco products, growing sales of legacy brands, and a stable dividend, making it a safe haven in volatile markets.
Philip Morris can market Zyn as lower risk than cigarettes
The FDA has authorized Philip Morris International to market 20 variants of its Zyn nicotine pouches as less harmful than cigarettes, marking the first time this distinction has been given to a nicotine pouch. This decision allows the company to state that Zyn poses less risk for diseases like lung cancer and stroke compared to combustible alternatives. Despite this authorization, an analyst suggests the impact on Zyn's market share may be limited as many consumers already recognize non-combustibles as less harmful, and competitors are expected to receive similar distinctions.
FDA Allows Philip Morris To Market Zyn Nicotine Pouches As Less Harmful Than Cigarettes
The FDA has given Philip Morris International authorization to market its Zyn nicotine pouches as a less harmful alternative to cigarettes. This decision allows Zyn to be promoted with claims of reduced risk for several serious diseases compared to cigarettes, based on scientific evidence. The ruling is a major win for Philip Morris, though critics remain concerned about cardiovascular risks and the product's appeal to new users.
FDA Authorizes Lower Disease Risk Claim for Select Philip Morris Zyn Nicotine Pouches
The FDA has authorized Philip Morris International's ZYN nicotine pouches to carry a lower disease risk claim, meaning they can now be marketed as reducing the risk of numerous smoking-related diseases when used as a complete substitute for cigarettes. This decision applies to 20 specific ZYN products and requires ongoing monitoring to assess consumer behavior and public health impact. While seen as a significant step for consumers, the FDA reiterates that no tobacco product is safe and non-users should not start.
Altria Group, Inc. (MO) Is a Trending Stock: Facts to Know Before Betting on It
Altria (MO) is currently a trending stock that has seen a 3.9% return over the past month, outperforming the S&P 500. The article analyzes Altria's earnings estimate revisions, projected revenue growth, and valuation, noting a Zacks Rank #3 (Hold). Current estimates are positive, with expected EPS of $1.48 for the current quarter and revenue growth predicted for both current and next fiscal years.
IFM Investors Pty Ltd Purchases 8,854 Shares of Philip Morris International Inc. $PM
IFM Investors Pty Ltd increased its stake in Philip Morris International Inc. by 3.9% in the first quarter, acquiring an additional 8,854 shares to reach a total of 233,395 shares valued at $38.6 million. This comes as Philip Morris International reported stronger-than-expected quarterly earnings and revenue, and declared a quarterly dividend of $1.47 per share. Analysts generally maintain a "Moderate Buy" rating for the stock with a consensus price target of $192.88.
iA Global Asset Management Inc. Reduces Stake in Philip Morris International Inc. $PM
iA Global Asset Management Inc. decreased its holdings in Philip Morris International Inc. (NYSE:PM) by 7.8% in Q1 2026, selling 36,970 shares and retaining 437,604 shares valued at $72.35 million. This reduction comes amid positive news for Philip Morris, including FDA authorization for 20 Zyn nicotine pouch products with reduced-risk claims, supporting the company's smoke-free strategy. The company also recently exceeded Q1 earnings and revenue expectations and announced a quarterly dividend of $1.47 per share, yielding approximately 3.3%.
Philip Morris International Inc. $PM Shares Sold by Alley Investment Management Company LLC
Alley Investment Management Company LLC reduced its stake in Philip Morris International (PM) by 4.9% in the first quarter, selling 8,504 shares and retaining 165,073 shares valued at $27.3 million. Despite this, Wall Street analysts maintain a "Moderate Buy" consensus with an average target price of $192.88, driven by the FDA's recent authorization of 20 Zyn nicotine pouch products with reduced-risk claims, which supports PMI's smoke-free strategy. The company also announced a quarterly dividend of $1.47 per share and reported strong Q1 earnings, surpassing analyst estimates.
Philip Morris International Inc. (NYSE:PM) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Philip Morris International (NYSE:PM) has received a consensus "Moderate Buy" rating from brokerages, with an average 1-year price target of $192.88. Key catalysts include FDA authorization for 20 Zyn nicotine pouch products to be marketed with reduced-risk claims, supporting PMI's smoke-free strategy, and better-than-expected quarterly results. The company reported EPS of $1.96 and revenue of $10.15 billion, also maintaining a quarterly dividend of $1.47 per share.
The WSJ Leadership Institute Names Philip Morris International Among “Best Companies For the Future”
Philip Morris International (PMI) has been recognized by the WSJ Leadership Institute as one of the "Best Companies for the Future," ranking 97th overall and third in the Food Beverage & Tobacco industry. This recognition highlights PMI’s commitment to a smoke-free future, driven by innovation, and its ability to adapt to a rapidly changing global environment. The ranking evaluates companies based on AI readiness, innovation, talent, financial fitness, resilience, and agility.
Philip Morris International Inc. stock outperforms competitors despite losses on the day
Philip Morris International Inc. (PM) stock experienced a 1.07% loss, closing at $180.91, despite a positive trading day for the broader market. This decline ended a five-day winning streak for the company's shares. The S&P 500 Index and the Dow Jones Industrial Average both saw gains on Tuesday.
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products
The FDA has issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products, making them the first nicotine pouches to receive such authorization. This allows Philip Morris International (PMI) to market ZYN with a claim that using them instead of cigarettes reduces the risk of several smoking-related diseases. The decision highlights the FDA's science-based approach to evaluating nicotine products and provides consumers with accurate information on reduced-risk alternatives.
Forum Financial Management LP Has $1.13 Million Stock Holdings in Philip Morris International Inc. $PM
Forum Financial Management LP reduced its stake in Philip Morris International (PM) by 51.6% in the first quarter, now owning 6,820 shares valued at approximately $1.13 million. Despite this reduction, Wall Street analysts maintain a "Moderate Buy" consensus rating with an average price target of $192.88. Philip Morris reported strong Q1 earnings, exceeding analyst estimates, and announced a quarterly dividend of $1.47 per share, yielding 3.2%.
Pictet Asset Management Holding SA Sells 28,893 Shares of Altria Group, Inc. $MO
Pictet Asset Management Holding SA reduced its stake in Altria Group by 3.6% in the first quarter, selling 28,893 shares and retaining 769,254 shares valued at $50.8 million. Altria recently exceeded earnings and revenue estimates, reporting EPS of $1.32 and revenue of $4.76 billion, while also raising its FY 2026 EPS guidance. The company maintains an attractive dividend yield of 5.7% but analysts generally rate the stock as "Hold."
Andrea Bocelli and Philip Morris International present “Believe. Further” initiative
Philip Morris International (PMI) and Maestro Andrea Bocelli have launched "Believe. Further," a multi-year initiative to promote progress and positive change. Unveiled in Venice, the platform challenges perceptions and highlights the transformative journeys of both Bocelli and PMI, the latter transitioning towards smoke-free products. The initiative aims to engage cultural, institutional, and business audiences across Europe, reflecting a shared belief in the importance of progress.
Philip Morris International prepays €1.0B on 5-year term loan, €1.5B remains
Philip Morris International prepaid €1.0 billion (approximately $1.1 billion) on its 5-year senior unsecured term loan facility. After this prepayment, €1.5 billion (approximately $1.7 billion) remains outstanding on this tranche, which matures on June 23, 2027. This action reduces the company's near-term debt.
Philip Morris (PM) prepays €1.0B, €1.5B term loan still due 2027
Philip Morris International Inc. announced on June 29, 2026, that it prepaid €1.0 billion (approximately $1.1 billion) of its senior unsecured term loan facility, including outstanding principal and accrued interest. Following this early repayment, €1.5 billion (approximately $1.7 billion) remains outstanding under the 5-year tranche, which is scheduled to expire on June 23, 2027. This prepayment reduces the company's debt burden while maintaining a significant portion of the loan with its original maturity date.
ETFs Investing in Bandwidth Inc. Class A Stocks
This article lists various ETFs that hold Bandwidth Inc. Class A stocks, providing details such as market value, weight, issuer, management style, focus, expense ratio, AUM, price, change percentage, relative volume, and 3-year NAV total return. The information helps investors identify funds with exposure to Bandwidth Inc. Class A, making stock investing more accessible with diversified options and potentially lower risk.
DIVN ETF Holdings List — CBOE:DIVN
The article provides a list of the top holdings for the Horizon Dividend Income ETF (DIVN) as of June 22, 2026. Key holdings include QUALCOMM, AbbVie, Philip Morris International, Procter & Gamble, and Merck & Co., detailing their weight percentage, number of shares, and market value. It also offers information on accessing deeper ETF data.
Philip Morris International Inc. stock rises Monday, still underperforms market
Philip Morris International Inc. (PM) shares increased by 1.16% on Monday, closing at $182.87. Despite this rise, the stock underperformed the broader market, as both the S&P 500 Index and the Dow Jones Industrial Average saw larger gains. This marks the fifth consecutive day of gains for Philip Morris International Inc.
Philip Morris International Partners With Andrea Bocelli to Promote Smoke-Free Products
Philip Morris International (PMI) has partnered with Italian tenor Andrea Bocelli for a "Believe. Further." initiative. This collaboration aims to promote PMI's transition towards smoke-free products through a series of performances and digital content. The campaign features Bocelli in a short film and musical performance, communicating PMI's goal to replace traditional cigarettes with alternative nicotine delivery systems globally.
What to Expect From Philip Morris' Q2 2026 Earnings Report
Philip Morris International Inc. (PM) is set to release its Q2 2026 earnings on Wednesday, July 22, with analysts projecting an EPS of $2.03, a 6.3% increase year-over-year. The tobacco company has consistently surpassed Wall Street's EPS estimates in the past four quarters and is expected to see continued EPS growth through fiscal 2027. Despite underperforming the S&P 500, analysts maintain a "Moderate Buy" rating for PM stock, anticipating an 8.8% upside from current levels.
Philip Morris International and Maestro Andrea Bocelli Present “Believe. Further”
Philip Morris International (PMI) and Maestro Andrea Bocelli have launched "Believe. Further," a multi-year platform aimed at fostering dialogue on progress and positive change. The initiative, announced in Venice, emphasizes shared beliefs in transformation and the ability of science and technology to create better choices. Maestro Bocelli's journey of conviction and PMI's commitment to a smoke-free future, with 43% of its net revenues from smoke-free products, exemplify the platform's core message.
